Morgan Stanley’s ENVUE MEDICAL INC NEW FEED Stock Holding History

Morgan Stanley’s Portfolio FEED Stock Details FEED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-833	Closed	-$23.8K	–	8531
2026 Q1	$23.8K	Buy	+833	New	+$21.6K	﹤0.01%	6659
2025 Q4	–	Sell	-83	Closed	-$5.64K	–	8384
2025 Q3	$5.64K	Buy	83 +74	+822%	+$6.68K	﹤0.01%	7058
2025 Q2	$954	Sell	9 -104	-92%	-$37.2K	﹤0.01%	7339
2025 Q1	$46.4K	Buy	+113	New	+$62.2K	﹤0.01%	6293
2024 Q2	–	Hold	0	–	-$9	–	7928
2024 Q1	–	Hold	0	–	–	–	7775
2023 Q4	–	Hold	0	–	–	–	7751
2023 Q3	–	Hold	0	–	–	–	7538
2023 Q2	–	Hold	0	–	–	–	7559
2023 Q1	–	Hold	0	–	–	–	7624
2022 Q4	–	Hold	0	–	–	–	7734
2022 Q3	–	Hold	0	–	–	–	7816
2022 Q2	–	Hold	0	–	–	–	7910
2022 Q1	–	Sell	-4	Closed	-$90.6K	–	8060
2021 Q4	$115K	Buy	4 +3	+300%	+$107K	﹤0.01%	6354
2021 Q3	$40K	Buy	+1	New	+$53.2K	﹤0.01%	6810
2019 Q4	–	Hold	0	–	–	–	6717
2019 Q3	–	Hold	0	–	–	–	6709
2019 Q2	–	Hold	0	–	–	–	6705
2019 Q1	–	Hold	0	–	–	–	6664
2018 Q3	–	Hold	0	–	–	–	6763
2018 Q2	–	Hold	0	–	–	–	6716

Other funds holding FEED

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Global Retirement Partners San Rafael, California $6.54B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley's FEED Position: Q2 2026 in Review

Morgan Stanley sold out of ENVUE MEDICAL INC NEW (FEED) in Q2 2026, closing a stake of 833 shares — an estimated $23.8K sold.

Morgan Stanley first reported a position in FEED in Q3 2021 and held it in 6 quarters. The position peaked at $115K in Q4 2021. 12 funds tracked by Wall St. Rank hold FEED as of Q2 2026.

Morgan Stanley reported no remaining ENVUE MEDICAL INC NEW position as of Q2 2026 after selling out during the quarter.
Morgan Stanley sold 833 ENVUE MEDICAL INC NEW shares in Q2 2026, an estimated $23.8K.
Morgan Stanley first reported a position in ENVUE MEDICAL INC NEW in Q3 2021 and held it in 6 quarters.
Morgan Stanley's ENVUE MEDICAL INC NEW position peaked at $115K in Q4 2021.
12 funds tracked by Wall St. Rank held ENVUE MEDICAL INC NEW as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.